(Q34305236)

English

Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls (English)

1 reference

Europe PubMed Central

1 August 2017

0 references

positron emission tomography

1 reference

based on heuristic

inferred from title

object named as

E Salmon

4

0 references

author name string

B Sadzot

1

1 reference

Europe PubMed Central

1 August 2017

C Lemaire

2

1 reference

Europe PubMed Central

1 August 2017

P Maquet

3

1 reference

Europe PubMed Central

1 August 2017

A Plenevaux

5

1 reference

Europe PubMed Central

1 August 2017

C Degueldre

6

1 reference

Europe PubMed Central

1 August 2017

J P Hermanne

7

1 reference

Europe PubMed Central

1 August 2017

M Guillaume

8

1 reference

Europe PubMed Central

1 August 2017

R Cantineau

9

1 reference

Europe PubMed Central

1 August 2017

D Comar

10

1 reference

Europe PubMed Central

1 August 2017

publication date

1 September 1995

1 reference

Europe PubMed Central

1 August 2017

Journal of Cerebral Blood Flow & Metabolism

1 reference

Europe PubMed Central

1 August 2017

15

1 reference

Europe PubMed Central

1 August 2017

5

1 reference

Europe PubMed Central

1 August 2017

787-797

1 reference

Europe PubMed Central

1 August 2017

describes a project that uses

positron emission tomography

1 reference

based on heuristic

inferred from title

Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

[18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Serotonin receptor changes in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Imaging the serotonergic system by positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

5-HT2 receptors, roles and regulation

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Central serotonergic S2 binding in Papio anubis measured in vivo with N-omega-[18F]fluoroethylketanserin and PET.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Serotonergic mechanisms in brains of suicide victims.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Serotonin receptors in the human brain--IV. Autoradiographic mapping of serotonin-2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Clinical pharmacokinetics of ketanserin

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Quantification of Human Opiate Receptor Concentration and Affinity Using High and Low Specific Activity [11C]Diprenorphine and Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Characterization and regional distribution of serotonin S2-receptors in human brain.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

The alteration of serotonin binding sites in aged human brain.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Aging and Alzheimer's disease. Altered cortical serotonergic binding.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Imaging dopamine receptors in the human brain by positron tomography.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

5HT2 receptor changes in major depression.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

21 January 2018

A Method for the In Vivo Investigation of the Serotonergic 5-HT2Receptors in the Human Cerebral Cortex Using Positron Emission Tomography and18F-Labeled Setoperone

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoradiographic localization of D1 and D2 dopamine receptors in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation in positron emission computed tomography: 1. Effect of object size

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

7 January 2021

based on heuristic

inferred from DOI database lookup

PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased serotonin-2 binding sites in frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1995.99

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/JCBFM.1995.99

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34305236&oldid=1877574000"